Pharma Journalist -

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Fasenra (benralizumab) for the treatment of Eosinophilic…
Read More...

The Mundipharma network of independent associated companies announced that the European Commission (EC) has granted approval for the use of Pelmeg (pegfilgrastim) as a treatment for…
Read More...

SMi’s Pharma is proud to announce the 3rd Annual Drug Discovery Chemistry Conference is back and the conference is taking place at the Copthorne Tara Hotel in London, UK on 18th and…
Read More...

Shanghai Roche Pharmaceuticals and Ascletis BioScience jointly announce that starting from 1st Dec 2018, Ascletis and Roche will expand their partnership in viral Hepatitis. Following…
Read More...

Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm announced a strategic development and commercialization collaboration to address unmet medical…
Read More...

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of Pancreatic…
Read More...

WuXi Biologics announced that construction of a global innovation center has commenced in the district of Fengxian in Shanghai. The new state-of-the-art biologics center will…
Read More...

Rare cancers inherently make it difficult to collect data, build clinical expertise and treat affected patients – challenges which are best addressed through collaboration in…
Read More...

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located…
Read More...

HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets of interest. In this…
Read More...